000752053 000__ 03397cam\a2200505Ii\4500
000752053 001__ 752053
000752053 005__ 20230306141353.0
000752053 006__ m\\\\\o\\d\\\\\\\\
000752053 007__ cr\cn\nnnunnun
000752053 008__ 151005t20162016ja\a\\\\ob\\\\000\0\eng\d
000752053 019__ $$a923359442$$a932333580
000752053 020__ $$a9784431555223$$q(electronic book)
000752053 020__ $$a4431555226$$q(electronic book)
000752053 020__ $$z9784431555216
000752053 020__ $$z4431555218
000752053 0247_ $$a10.1007/978-4-431-55522-3$$2doi
000752053 035__ $$aSP(OCoLC)ocn922887184
000752053 035__ $$aSP(OCoLC)922887184$$z(OCoLC)923359442$$z(OCoLC)932333580
000752053 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dIDEBK$$dCDX$$dOCLCF$$dYDXCP$$dEBLCP$$dAZU$$dDEBSZ$$dGW5XE
000752053 049__ $$aISEA
000752053 050_4 $$aRC280.C6
000752053 08204 $$a616.994347$$223
000752053 24500 $$aColitis-associated cancer$$h[electronic resource] /$$cMasato Kusunoki, editor.
000752053 264_1 $$aTokyo ;$$aNew York :$$bSpringer,$$c[2016]
000752053 264_4 $$c©2016
000752053 300__ $$a1 online resource (iii, 150 pages) :$$billustrations
000752053 336__ $$atext$$btxt$$2rdacontent
000752053 337__ $$acomputer$$bc$$2rdamedia
000752053 338__ $$aonline resource$$bcr$$2rdacarrier
000752053 504__ $$aIncludes bibliographical references.
000752053 5050_ $$aChapter 1 Colitis-Associated Cancer: Overview -- Part I Clinical Features -- Chapter 2 Incidence and Risk Factors -- Chapter 3 Prevention and Prognosis -- Part II. Diagnosis -- Chapter 4 Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- Chapter 5 Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- Chapter 6 Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- Chapter 7 Surgical Treatment for Colorectal Cancer in Crohn's Disease.
000752053 506__ $$aAccess limited to authorized users.
000752053 520__ $$aAs the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
000752053 588__ $$aOnline resource; title from PDF title page (viewed October 7, 2015).
000752053 650_0 $$aInflammatory bowel diseases.
000752053 650_0 $$aUlcerative colitis.
000752053 650_0 $$aCrohn's disease.
000752053 650_0 $$aRectum$$xCancer.
000752053 650_0 $$aColon (Anatomy)$$xCancer.
000752053 7001_ $$aKusunoki, Masato,$$eeditor.
000752053 77608 $$iPrint version:$$z4431555218$$z9784431555216$$w(OCoLC)903284683
000752053 852__ $$bebk
000752053 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-4-431-55522-3$$zOnline Access$$91397441.1
000752053 909CO $$ooai:library.usi.edu:752053$$pGLOBAL_SET
000752053 980__ $$aEBOOK
000752053 980__ $$aBIB
000752053 982__ $$aEbook
000752053 983__ $$aOnline
000752053 994__ $$a92$$bISE